Terbutaline prodrugs and oral beta 2-agonist therapy.
Svensson
L A
LA
Department of Medicinal Chemistry, Preclinical R & D, Astra Draco AB, Lund, Sweden.
D000284:Administration, Oral; D000318:Adrenergic beta-Agonists / Q000493:pharmacokinetics*; D000818:Animals; D004285:Dogs; D006168:Guinea Pigs; D006801:Humans; D011355:Prodrugs / Q000493:pharmacokinetics*; D013726:Terbutaline / Q000031:analogs & derivatives / Q000493:pharmacokinetics*
D000318:Adrenergic beta-Agonists; D011355:Prodrugs; D013726:Terbutaline; C047766:bambuterol